| 词条 | Pirarubicin |
| 释义 | {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 408701869 | IUPAC_name = (3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranoside | image = Pirarubicin.png | tradename = | Drugs.com = {{drugs.com|international|pirarubicin}} | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Rx-only | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 72496-41-4 | ATC_prefix = L01 | ATC_suffix = DB08 | ATC_supplemental = | PubChem = 3033521 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | UNII_Ref = {{fdacite|changed|FDA}} | UNII = D58G680W0G | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D01885 | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 1398373 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 2298189 | chemical_formula = | C=32 | H=37 | N=1 | O=12 | molecular_weight = 627.63 g/mol | smiles = C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O[C@@H]6CCCCO6 | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19?,21+,22-,31+,32-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = KMSKQZKKOZQFFG-YHKVCKOMSA-N | synonyms = (9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | melting_point = 188 | melting_high = 192 | melting_notes = (decomposes) }} Pirarubicin (INN) is an anthracycline drug. An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin and exhibits activity against some doxorubicin-resistant cell lines. {{Chemotherapeutic agents}}{{antineoplastic-drug-stub}} 6 : Anthracyclines|Topoisomerase inhibitors|Tetrahydropyrans|Phenols|Phenol ethers|DNA intercalaters |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。